A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies? - ScienceDirect
Antioxidants as Complementary Medication in Thalassemia | IntechOpen
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica
β-Thalassemia | Genetics in Medicine
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica
Beta Thalassemia: New Therapeutic Options Beyond Transfusion and Iron Chelation | SpringerLink
Pathophysiology and treatment of patients with... | F1000Research
Frontiers | New Insights Into Pathophysiology of β-Thalassemia
Tricuspid-valve regurgitant jet velocity as a risk factor for death in β- thalassemia | Haematologica
Sirolimus for Treatment of β-Thalassemia: From Pre-Clinical Studies to the Design of Clinical Trials
Biomolecules | Free Full-Text | Epigenetic Insights and Potential Modifiers as Therapeutic Targets in β–Thalassemia
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica
Current status of beta‐thalassemia and its treatment strategies - Ali - 2021 - Molecular Genetics & Genomic Medicine - Wiley Online Library
Replacing the suppressed hormone: toward a better treatment for iron overload in β-thalassemia major? | Haematologica
IJMS | Free Full-Text | Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management
Current and future alternative therapies for beta-thalassemia major - ScienceDirect
Significance of genetic modifiers of hemoglobinopathies leading towards precision medicine | Scientific Reports
Guidelines for the Management of Transfusion-Dependent Thalassaemia (4th Edition - Version 2.0) by Thalassaemia International Federation (TIF) - Issuu
New treatment strategies for β-thalassemia | Encyclopedia MDPI
2021 update on clinical trials in β‐thalassemia - Musallam - 2021 - American Journal of Hematology - Wiley Online Library
Frontiers | The Future of Gene Therapy for Transfusion-Dependent Beta- Thalassemia: The Power of the Lentiviral Vector for Genetically Modified Hematopoietic Stem Cells
Thalassaemia - The Lancet
Non-transfusion-dependent thalassemias | Haematologica
Gene Therapy For Beta-Thalassemia: Updated Perspectives | TACG
